A potential improved treatment for two of the leading causes of blindness – age and diabetes-related eye problems ...
The first award under BioCurate’s new “Proof of Concept” fund has been granted to Australia's Monash B...
APAC is home to over 60% of the world’s population and the economical benefits of having a biopharma industry in t...
A team of researchers at the China Medical University Hospital in Taiwan has sought to determine whether pelvic inf...
A nasal spray technology that enables the delivery of psychedelic and non-psychedelic drugs to treat mental health disor...
New research from Monash University has found that a non-drug sleep program, using Cognitive Behavioural Therapy (CBT), ...
The faecal immunochemical test (FIT) is commonly used to screen for colorectal cancer but it has low sensitivity (around...
Hummingbird Bioscience, an innovative clinical-stage biotech company with its APAC headquarter in Singapore, is focused ...
American biopharma firm Gilead Sciences, Inc. has announced the launch of the 2021 Gilead Asia Pacific ALL4LIVER Grant, ...
Deargen, an artificial intelligence (AI)-powered drug discovery and development startup, has signed an agreement with So...
A team of international scientists from Nanyang Technological University, Singapore (NTU Singapore), Tan Tock Seng Hospi...
Scientists at Japan-based Kyoto University’s Institute for Integrated Cell-Material Sciences (iCeMS) and colleague...
Alzheimer’s Disease (AD), the most common type of dementia, causes the death of neurons and leads to shrinking of ...
In an email interaction with BioSpectrum, EpimAb’s Founder and CEO, Dr Chengbin Wu tells us more about the company...
Pharmacologists at the University of Sydney in Australia have found tantalising clues as to why low-dose CBD products co...
Inhalon Biopharma, Inc., a US-based clinical-stage immunotherapy company developing an inhaled "muco-trapping" anti...
Novigenix SA, a leading Swiss biotech that develops and commercializes Immuno-Transcriptomic precision oncology solution...
Dr Stephen Inns and his team from the University of Otago, in New Zealand (NZ) have secured almost $250,000 from the Hea...
